Abstract: The invention relates to a process for the preparation of azelaic acid or alkyl azelate starting from mono-unsaturated 9-octadecenedioic acid or its corresponding alkylester characterized in that the process comprises at least the following step: •reacting the mono-unsaturated 9-octadecene dioic acid or its corresponding alkylester with hydrogen peroxide in the presence of an organic carboxylic acid other than 9-octadecene dioic acid and a suitable catalyst to effect cleavage of the double bond in the mono-unsaturated 9-octadecene dioic acid or its corresponding alkylester. The invention further relates to the azelaic acid or alkyl azelate obtainable by the process according to the invention and to the use of azelaic acid or alkyl azelate or monomers derived there from for the preparation of a polymer, especially a polyamide.

Abstract: A variant polypeptide having alpha-amylase activity is disclosed. The variant polypeptide has an amino acid sequence which, when aligned with the alpha-amylase comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid residue with reference to SEQ ID NO: 2. The variant polypeptide has one or more altered properties as compared with a reference polypeptide having alpha-amylase activity. Such a variant polypeptide may be used in the preparation of a baked product.

Abstract: The present invention provides systems for producing engineered oleaginous yeast or fungi that express retinolic compounds.

Abstract: The present invention relates to a new and improved synthesis of peretinoin.

Abstract: The present invention relates to novel compositions for treating seeds. Moreover, the present invention is directed to the production of these compositions and the uses of these compositions.

Abstract: There is described a process for producing a gel free hyperbranched polyamide polymer having primary amino groups (useful as a crosslinker). The process comprises the step of reacting at least one diamine and at least one unsaturated diester in a molar ratio of diamine to diester greater than 1 but less than 3 (preferably 2.1 to 2.9); to form the polyamide in a two stage reaction Michael addition and then amidation. The diamine in kept in excess with at least 5% of water by total weight of the diamine and diester, a reaction temperature less than the boiling point of the diamine; and is held under reduced pressure (30 mbar to 1 atms). Gelation does not occur even after substantially all ethylenic (—C?C—) double bonds; and >95% ester [—C(O)?O] groups have reacted. This violates the Flory rules which predict a gel would form based on the number of functional groups present and their degree of conversion.

Abstract: The invention relates to a heat-curable powder coating composition comprising i) at least one crystalline polyester resin present in an amount of at most 90 wt %; and ii) at least one amorphous polyester resin; and iii) at least one crosslinking agent; and iv) at least one thermal radical initiator, wherein, the at least one crystalline polyester resin and/or the at least one amorphous polyester resin has di-acid ethylenic unsaturations; wherein the at least one crosslinking agent is either crystalline or amorphous; wherein the at least one crosslinking agent has reactive unsaturations that are reactable with the ethylenic unsaturations of the di-acid ethylenic unsaturations of the at least one crystalline polyester resin and/or the at least one amorphous polyester resin to be crosslinked, said unsaturations of the crosslinking agent are different from the unsaturations of the at least one crystalline polyester resin and the unsaturations of the at least amorphous polyester resin; wherein the wt % is based on

Abstract: The invention relates to a process for producing an (ultra) high molecular weight polyethylene (HMWPE) article comprising: incorporating into the HMWPE resin a Hindered Amine Light Stabilizer (HALS) and cross-link the (U)HMWPE during or after molding the (U)HMWPE resin.

Abstract: The present invention is related to a new metal powder catalytic system (catalyst) comprising a cobalt/chrome-alloy as a carrier, its production and its use in hydrogenation processes.

Abstract: The present invention relates to a fluid composition comprising water and a self-emulsifying cosmetic base consisting of resveratrol, a liquid phosphate ester surfactant, at least one cosmetic oil and optionally a co-emulsifier. The present invention also relates to the process to make such fluids.

Abstract: The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the full-length polynucleotide sequences of the novel genes and fragments thereof, the novel polypeptides encoded by the polynucleotides and fragments thereof, as well as their functional equivalents. The present invention also relates to the use of the polynucleotides and polypeptides as biotechnological tools in the production of Vitamin C from microorganisms, whereby a modification of the polynucleotides and/or encoded polypeptides has a direct or indirect impact on yield, production, and/or efficiency of production of the fermentation product in the microorganism. Also included are methods/processes of using the polynucleotides and modified polynucleotide sequences to transform host microorganisms.

Abstract: The present invention relates to pharmaceutically acceptable amine salts of pitavastatin and a method for producing pharmaceutically acceptable amine salts of pitavastatin. Also provided are pharmaceutical compositions of these amine salts or solvates thereof, and methods of their use as HMG-CoA reductase inhibitors.

Abstract: Plastic bodies are formed of two polyamide parts welded together, wherein the two polyamide parts consist of a polyamide composition at least one which comprises an iron containing additive. The welding process for making the plastic body includes welding two polyamide parts, at least one of which consists of a polyamide composition comprising an iron containing additive.

Abstract: The present invention relates to a method for reducing the production of methane emanating from the digestive activities of a ruminant and/or for improving ruminant animal performance by using, as active compound at least one organic molecule substituted at any position with at least one nitrooxy group, or a salt thereof, which is administrated to the animal together with the feed. The invention also relates to the use of these compounds in feed and feed additives such as premix, concentrates and total mixed ration (TMR) or in the form of a bolus.

Abstract: The invention relates to a polypeptide which comprises the amino acid sequence set out in SEQ ID NO: 2 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 1, or a variant polypeptide or variant polynucleotide thereof, wherein the variant polypeptide has at least 76% sequence identity with the sequence set out in SEQ ID NO: 2 or the variant polynucleotide encodes a polypeptide that has at least 76% sequence identity with the sequence set out in SEQ ID NO: 2. The invention features the full length coding sequence of the novel gene as well as the amino acid sequence of the full-length functional polypeptide and functional equivalents of the gene or the amino acid sequence. The invention also relates to methods for using the polypeptide in industrial processes. Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.

Abstract: Sugar premix containing crystal sugar particles comprising a sugar core which is coated with a mixture of one or more polysaccharides and/or one or more oligosaccharides said coating further containing one or more nutrients, processes for their manufacture and uses.

Abstract: A water dilutable UV-curable polyurethane containing alkylene oxide groups, the polyurethane being obtained from components comprising at least: (i) 1 to 25 wt. % of at least one polyisocyanate; (ii) 0 to 80 wt. % of at least one hydroxyl functional compound containing alkylene oxide groups; (iii) 10 to 90 wt. % of at least one hydroxyl functional compound containing at least one polymerizable unsaturated (meth)acryloyl functional group per molecule; and (iv) 0 to 50 wt. % of at least one isocyanate-reactive compound not comprised by (ii) or (iii); wherein the sum of (i) to (iv) is 100%.

Abstract: The present invention relates to a process for the preparation of a precursor for the synthesis of hexanoic acid derived statins and to the use of said precursor in the manufacture of a medicament.

Abstract: Process for removing residual spin solvent from a gel spun, UHMwPE filament having an effective diameter of above 16 ?m, comprising the steps of: removing residual spin solvent from the filament to a level of below 100 ppm at elevated temperature, while keeping the filament taut. The invention also relates to gel spun UHMwPE filament having an effective diameter of above 16 ?m and a residual spin solvent residue of less than 100 ppm. Preferably the filament has a creep rate, measured at 50° C., under a load, so that the initial stress is 600 MPa, of less than 510?6 sec?1.